Protecting Democracy [1]

American democracy is in jeopardy, from the disastrous Citizens United ruling that flooded our politics with corporate cash to the immoral assault on voting rights. We work every day to defend against these threats and advance bold reforms.

Tell Congress: Pass the Protecting Our Democracy Act

Add Your Name

Generative Artificial Intelligence and Threats to Democracy

Protecting Elected Officials from Threats
Making Government Work [2]

The U.S. government should work for the public, not corporations or industry. It should safeguard consumers, workers and the environment, and be funded well enough to do so. The budget process must not be obstructed by partisanship.

Get Corporate Money Out of Politics

Sign the Petition

It’s Time to Cut the Bloated Pentagon Budget to Fund People, Not Military Contractors

Ensuring Public Money Does Not Go To Private Equity
Consumer & Worker Safeguards [3]

Every day, Big Banks, Big Polluters, and Big Tech companies are threatening our economy, our environment, and our democracy – sacrificing Main Street Americans and our families on the altar of corporate profits. Public Citizen advocates for ordinary people by taking on corporate interests and their cronies in government.

Don’t Let Big Tech Write Our Digital Privacy Laws

Sign Now

Public Citizen Calls on Presidential Candidates, Parties to Pledge Not to Use Dangerous, Manipulative Deepfakes

Within Reach: Banker Pay Reform
Safe & Affordable Drugs & Devices [4]

Prescription drugs are unaffordable and new drugs and devices often are approved without being proven safe and effective. Public Citizen challenges Big Pharma, device manufacturers and federal regulators to make drugs and medical devices safe, effective and accessible to all.

Tell President Biden: Make Meds Affordable

SEND AN EMAIL
Health Care [5]

Health care in the U.S. leaves too many people out, costs too much and doesn’t meet acceptable standards of quality. Much of the care that we get is unaffordable, unnecessary or harmful. Public Citizen advocates Medicare for All, stronger oversight of dangerous doctors and safe clinical trials.

Win Medicare for All

Take Action Now

Report: Ranking of the Rate of State Medical Boards’ Serious Disciplinary Actions, 2021-2023

Report: Thirty-One Years of Pharmaceutical Industry Criminal and Civil Penalties: 1991-2021
Globalization & Trade [6]

Global Trade Watch’s mission is to ensure that in this era of globalization, a majority have the opportunity to enjoy economic security, a healthy environment, safe food, medicines and products, access to quality affordable services such as health care and the exercise of democratic decision-making about the matters that affect our lives.

Global Trade Watch has led the fight against corporate-rigged “trade” agreements that provide special powers for Big Pharma to raise medicine prices, promote the outsourcing of jobs to low-wage countries and undermine the food safety and other safeguards on which our families rely.

For decades, we have fought for progressive alternatives that benefit people and the planet. Learn more about our work.

Join the Trade Justice Movement

JOIN NOW
Climate & Energy [7]

The climate crisis is the challenge of our time. We can fix it with solutions that will make us healthier and more economically secure. We must act quickly to make our economy run on renewable power — and ensure that disadvantaged families and displaced workers share equitably in the new economy. We also must fight the corrupting power of fossil fuel companies and ensure that energy regulators are effective and publicly accountable.

Tell Toyota: Go all-in on EVs

Add Your Name

Climate Roadmap for U.S. Financial Regulation

Toyota’s Troubling Electric Vehicle Track Record
Justice & the Courts [8]

Litigation can remedy or deter wrongdoing, impact policy and meaningfully slow abuses of power. Whether suing on behalf of our members to ensure the honest functioning of government, or representing individual consumers seeking redress in court, our litigation draws on our expertise in administrative law, constitutional law, and government transparency.

Subscribe to the Supreme Court Conference Preview

Sign Up

Working to ensure implementation of laws protecting health and safety

What you should know

Since 1972, Public Citizen has worked to ensure that federal laws enacted to protect public health and safety are implemented properly and on a timely basis. Litigation brought under the Administrative Procedure Act complements our policy work in the areas of drug and medical device safety, food safety, auto safety, and consumer product safety.

Our Litigation

ACLA v. FDA

November 4, 2024

The 1976 Medical Device Amendments to the Food, Drug, and Cosmetic Act (FDCA) authorize the Food and Drug Administration (FDA)…

Novartis Pharmaceuticals Corp. v. Becerra

October 18, 2024

The Inflation Reduction Act (IRA) of 2022 contains several reforms designed to lower the high cost of prescription drugs and…

Bristol Myers Squibb Co. v. Becerra; Janssen Pharmaceuticals v. Becerra

September 16, 2024

The Inflation Reduction Act (IRA) of 2022 contains several reforms designed to lower the high cost of prescription drugs and…

Cox v. Total Quality Logistics

September 6, 2024

Total Quality Logistics (TQL) is a freight broker that arranged for Golden Transit Inc. to transport a load of goods…

Dayton Area Chamber of Commerce v. Becerra

August 8, 2024

The Inflation Reduction Act (IRA) of 2022 contains several reforms designed to lower the high cost of prescription drugs and…

Csoka v. FDA

August 5, 2024

We represent Dr. Antonei B. Csoka in a case against the U.S. Food and Drug Administration (FDA) seeking to compel…

Our Work

We work to protect and advance consumer health and safety. See our legal briefs, articles, and policy papers on advocating for strong health and safety regulation.

Press Releases

Office of Inspector General at Department of Health and Human Services Should Investigate Conflict of Interest Allegations Against Senior FDA Official

August 20, 2024

Press Releases

Stay Updated on Health & Safety

Follow Public Citizen

Support Our Work

Donate

Tell Congress: Pass the Protecting Our Democracy Act

Generative Artificial Intelligence and Threats to Democracy

Protecting Elected Officials from Threats

Get Corporate Money Out of Politics

It’s Time to Cut the Bloated Pentagon Budget to Fund People, Not Military Contractors

Ensuring Public Money Does Not Go To Private Equity

Don’t Let Big Tech Write Our Digital Privacy Laws

Public Citizen Calls on Presidential Candidates, Parties to Pledge Not to Use Dangerous, Manipulative Deepfakes

Within Reach: Banker Pay Reform

Tell President Biden: Make Meds Affordable

Win Medicare for All

Report: Ranking of the Rate of State Medical Boards’ Serious Disciplinary Actions, 2021-2023

Report: Thirty-One Years of Pharmaceutical Industry Criminal and Civil Penalties: 1991-2021

Join the Trade Justice Movement

Tell Toyota: Go all-in on EVs

Climate Roadmap for U.S. Financial Regulation

Toyota’s Troubling Electric Vehicle Track Record

Subscribe to the Supreme Court Conference Preview

What you should know

Our Litigation

ACLA v. FDA

Novartis Pharmaceuticals Corp. v. Becerra

Bristol Myers Squibb Co. v. Becerra; Janssen Pharmaceuticals v. Becerra

Cox v. Total Quality Logistics

Dayton Area Chamber of Commerce v. Becerra

Csoka v. FDA

Our Work

FDA Slow to Ban Ineffective Over-the-Counter Oral Phenylephrine

Patient, Research, and Provider Groups File Amicus Brief Supporting FDA’s Rule on Laboratory Developed Tests

Public Citizen’s Health Letter

Medicare Could Save $14 Billion with Access to Ozempic and Wegovy Generics

Ozempic could be $100 if the Feds Act Now

Office of Inspector General at Department of Health and Human Services Should Investigate Conflict of Interest Allegations Against Senior FDA Official

First round of Medicare Drug Price Negotiations Promising Steps against Pharma Profiteering

FDA was Right to Decline Approval of MDMA-Assisted Therapy for PTSD and Encourage Further Research

Novo Nordisk’s $50 billion in Ozempic & Wegovy Sales Comes at the Expense of Healthcare Solvency

Stay Updated on Health & Safety

Follow Public Citizen

Support Our Work